VEGF receptor signalling, specifically VEGFR2, can lead to the activation of the downstream kinases Src and FAK, which induce the expression of Rho-GTPases (126, 127), whose activation results in the inhibition of cell migration and invasion (128); therefore, VEGFR knockdown reduces tumor migration. The gene discussed is KDR; the disease is neoplasm.